APA (7th ed.) Citation

LL, F., V, B., F, P., S, L., TB, N., & H, B. (2005). OAS1 splice site polymorphism controlling antiviral enzyme activity influences susceptibility to type 1 diabetes. Diabetes, 54(5), 1588. https://doi.org/10.2337/diabetes.54.5.1588

Chicago Style (17th ed.) Citation

LL, Field, Bonnevie-Nielsen V, Pociot F, Lu S, Nielsen TB, and Beck-Nielsen H. "OAS1 Splice Site Polymorphism Controlling Antiviral Enzyme Activity Influences Susceptibility to Type 1 Diabetes." Diabetes 54, no. 5 (2005): 1588. https://doi.org/10.2337/diabetes.54.5.1588.

MLA (9th ed.) Citation

LL, Field, et al. "OAS1 Splice Site Polymorphism Controlling Antiviral Enzyme Activity Influences Susceptibility to Type 1 Diabetes." Diabetes, vol. 54, no. 5, 2005, p. 1588, https://doi.org/10.2337/diabetes.54.5.1588.